Search research articles
Contact Us
Filters
Showing results (181-190 of 317) with videos related to
Page
of 32
Sort By:
Therapeutic Advances in Neurological Disorders
|
June 9, 2021
Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis
Caspar B Seitz, Falk Steffen, Muthuraman Muthuraman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
GWAS highlights the neuronal contribution to multiple sclerosis susceptibility
Lu Zeng, Khan Atlas, Tsering Lama, et al.
Plos One
|
April 10, 2008
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis
Friedemann Paul, Sonia Waiczies, Jens Wuerfel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 21, 2016
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment
Ulrike Bühler, Vinzenz Fleischer, Felix Luessi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 25, 2017
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS
Vinzenz Fleischer, Michaela Friedrich, Ayman Rezk, et al.
Archives of Neurology
|
February 16, 2011
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis
Olaf Stüve, Joanne Wang, Andrew Chan, et al.
Journal of Neuroimmunology
|
March 17, 2004
Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis
Alexandra Weber, Klaus-Peter Wandinger, Wolf Mueller, et al.
Nature Cell Biology
|
March 18, 2008
Sirt1 contributes critically to the redox-dependent fate of neural progenitors
Timour Prozorovski, Ulf Schulze-Topphoff, Robert Glumm, et al.
The Journal of Clinical Investigation
|
June 16, 2007
TRAIL limits excessive host immune responses in bacterial meningitis
Olaf Hoffmann, Josef Priller, Timour Prozorovski, et al.
Therapeutic Advances in Neurological Disorders
|
June 29, 2023
Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial
Sinah Engel, Luisa Klotz, Timo Wirth, et al.
Page
of 32
Search research articles
Search
Showing results (181-190 of 317) with videos related to
Sort By:
Page
of 32
Therapeutic Advances in Neurological Disorders
|
June 9, 2021
Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis
Caspar B Seitz, Falk Steffen, Muthuraman Muthuraman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
GWAS highlights the neuronal contribution to multiple sclerosis susceptibility
Lu Zeng, Khan Atlas, Tsering Lama, et al.
Plos One
|
April 10, 2008
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis
Friedemann Paul, Sonia Waiczies, Jens Wuerfel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 21, 2016
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment
Ulrike Bühler, Vinzenz Fleischer, Felix Luessi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 25, 2017
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS
Vinzenz Fleischer, Michaela Friedrich, Ayman Rezk, et al.
Archives of Neurology
|
February 16, 2011
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis
Olaf Stüve, Joanne Wang, Andrew Chan, et al.
Journal of Neuroimmunology
|
March 17, 2004
Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis
Alexandra Weber, Klaus-Peter Wandinger, Wolf Mueller, et al.
Nature Cell Biology
|
March 18, 2008
Sirt1 contributes critically to the redox-dependent fate of neural progenitors
Timour Prozorovski, Ulf Schulze-Topphoff, Robert Glumm, et al.
The Journal of Clinical Investigation
|
June 16, 2007
TRAIL limits excessive host immune responses in bacterial meningitis
Olaf Hoffmann, Josef Priller, Timour Prozorovski, et al.
Therapeutic Advances in Neurological Disorders
|
June 29, 2023
Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial
Sinah Engel, Luisa Klotz, Timo Wirth, et al.
Page
of 32